Suppressor-type TERT mutations associated with recurrence in ovarian clear cell carcinoma

被引：1
|
作者：
Kobayashi, Tatsuya [1 ,3 ]
Nishikimi, Kyoko [1 ,3 ]
Mitsuhashi, Akira [1 ,2 ]
Piao, Hongying [1 ]
Matsuoka, Ayumu [1 ]
Otsuka, Satoyo [1 ]
Tate, Shinichi [1 ]
Shozu, Makio [1 ]
Usui, Hirokazu [1 ]
机构：
[1] Chiba Univ, Grad Sch Med, Dept Reprod Med, Chiba, Japan
[2] Dokkyo Med Univ, Sch Med, Dept Obstet & Gynecol, Mibu, Tochigi, Japan
[3] Chiba Univ, Dept Reprod Med, Inohana 1-8-1, Chuo-ku, Chiba, Chiba 2608670, Japan
来源：
GENES CHROMOSOMES & CANCER | 2023年 / 62卷 / 08期
基金：
日本学术振兴会;
关键词：
enhancer-type" TERT promoter mutation; suppressor-type" TERT promoter mutation; ovarian cancer; ovarian clear cell carcinoma; recurrence; telomerase reverse transcriptase; telomere; REVERSE-TRANSCRIPTASE PROMOTER; TELOMERASE; ENDOMETRIAL; RESISTANCE; MECHANISMS;
D O I：
10.1002/gcc.23129
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Several cancers harbor "enhancer-type" mutations of the telomerase reverse transcriptase (TERT) promoter for immortalization. Here, we report that 8.6% (8/93) of ovarian clear cell carcinomas (OCCCs) possess the "suppressor-type" TERT promoter mutation. The recurrence rate of OCCCs with "suppressor-type" TERT promoter mutations was 62.5% (5/8) and was significantly higher than that of the "unaffected-type" with no mutation (20.8%, 15/72) or "enhancer-type" TERT promoter mutations (7.7%, 1/13). Our findings show that the acquired suppression of TERT is closely associated with OCCC development and recurrence, indicating the need for further research on telomerase suppression in cancers.
引用
收藏
页码：471 / 476
页数：6
相关论文
共 50 条
  • [1] TERT promoter mutations in clear cell renal cell carcinoma
    Hosen, Ismail
    Rachakonda, P. Sivaramakrishna
    Heidenreich, Barbara
    Sitaram, Raviprakash T.
    Ljungberg, Borje
    Roos, Goran
    Hemminki, Kari
    Kumar, Rajiv
    INTERNATIONAL JOURNAL OF CANCER, 2015, 136 (10) : 2448 - 2452
  • [2] RECURRENCE PATTERN IN PATIENTS WITH OVARIAN CLEAR CELL CARCINOMA
    Yuda, Sayako
    Yunokawa, Mayu
    Shimoi, Tatsunori
    Sasaki, Sayuri
    Koudaira, Makoto
    Yamamoto, Harukaze
    Yonemori, Kan
    Shimizu, Chikako
    Fujiwara, Yasuhiro
    Tamura, Kenji
    ANNALS OF ONCOLOGY, 2014, 25
  • [3] Ovarian clear cell carcinoma with uterine intramural recurrence: Case report of ovarian clear cell carcinoma with fertility sparing treatment
    Chang, Ting Yu
    Yeh, Chiung-Yi
    Yang, Chih-Yi
    Lin, Wu-Chou
    Huang, Chien-Chu
    Hung, Yao-Ching
    TAIWANESE JOURNAL OF OBSTETRICS & GYNECOLOGY, 2024, 63 (01): : 90 - 94
  • [4] Clinicopathological and Prognostic Values of Telomerase Reverse Transcriptase (TERT) Promoter Mutations in Ovarian Clear Cell Carcinoma for Predicting Tumor Recurrence, Platinum Resistance and Survival
    Yoo, Hyunwoo
    Kim, Hyun-Soo
    CANCER GENOMICS & PROTEOMICS, 2023, 20 (06) : 626 - 636
  • [5] Ovarian clear cell carcinoma recurrence presenting as subcutaneous nodules
    Wade, J.
    Armon, S.
    McNally, O. M.
    EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY, 2016, 37 (04) : 575 - 577
  • [6] Clear cell/endometrioid type ovarian carcinoma associated with endometriosis of the ipsilateral ovary
    Biljic-Erski, Ivana Rudic
    Vasiljevic, Mladenko
    Rakic, Snezana
    Dzatic-Smiljkovic, Olivera
    Mihajlovic, Sladjana
    VOJNOSANITETSKI PREGLED, 2019, 76 (05) : 547 - 551
  • [7] Recurrence factors of stage I ovarian clear cell carcinoma.
    Takei, Yuji
    Fujiwara, Hiroyuki
    Machida, Shizuo
    Taneichi, Akiyo
    Takahashi, Suzuyo
    Takahashi, Yoshifumi
    Saga, Yasushi
    Suzuki, Mitsuaki
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [8] Patterns of recurrence and impact on survival in patients with clear cell ovarian carcinoma
    Hogen, Liat
    Vicus, Danielle
    Ferguson, Sarah Elizabeth
    Gien, Lilian T.
    Nofech-Mozes, Sharon
    Lennox, Genevieve K.
    Bernardini, Marcus Q.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2019, 29 (07) : 1164 - 1169
  • [9] Genetic mutations associated with metastatic clear cell renal cell carcinoma
    Li, Zhongjun
    Hao, Ping
    Wu, Qingjian
    Li, Fengjie
    Zhao, Jiang
    Wu, Kaijin
    Qu, Cunye
    Chen, Yibu
    Li, Meng
    Chen, Xuelian
    Stucky, Andres
    Zhong, Jiangjian
    Li, Longkun
    Zhong, Jiang F.
    ONCOTARGET, 2016, 7 (13) : 16172 - 16179
  • [10] Immune-Hot tumor features associated with recurrence in early-stage ovarian clear cell carcinoma
    Huang, Ruby Yun-Ju
    Huang, Kuan-Ju
    Chen, Ko-Chen
    Hsiao, Sheng-Mou
    Tan, Tuan Zea
    Wu, Chin-Jui
    Hsu, Ching
    Chang, Wen-Chun
    Pan, Chen-Yu
    Sheu, Bor-Ching
    Wei, Lin-Hung
    INTERNATIONAL JOURNAL OF CANCER, 2023, 152 (10) : 2174 - 2185
12345